Obestatin signalling counteracts glucocorticoid‐induced skeletal muscle atrophy via NEDD4/KLF15 axis

BACKGROUND: A therapeutic approach for the treatment of glucocorticoid‐induced skeletal muscle atrophy should be based on the knowledge of the molecular mechanisms determining the unbalance between anabolic and catabolic processes and how to re‐establish this balance. Here, we investigated whether t...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Cachexia Sarcopenia Muscle
Egile Nagusiak: Cid‐Díaz, Tania, Leal‐López, Saúl, Fernández‐Barreiro, Fátima, González‐Sánchez, Jessica, Santos‐Zas, Icía, Andrade‐Bulos, Luis J., Rodríguez‐Fuentes, Manuel E., Mosteiro, Carlos S., Mouly, Vincent, Casabiell, Xesús, Relova, Jose Luis, Pazos, Yolanda, Camiña, Jesus P.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2021
Gaiak:
Original Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8061369/
https://ncbi.nlm.nih.gov/pubmed/33687156
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcsm.12677
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak